India’s generics supply to US in jeopardy
U.S. regulators are mobilizing to shore up confidence in America’s generic-drug supply as alarm grows over the quality of products made in India, and the head of the largest U.S.-based maker of the medicines predicted more trouble lies ahead. “It’ll get worse before it gets better,” said Mylan (MYL) Inc. Chief Executive Officer Heather Bresch, whose company has half of its more than 20,000 employees in India. […]